Tralokinumab |
| カタログ番号GC66350 |
完全ヒト IgG4 モノクローナル抗体であるトラロキヌマブは、IL-13 のみに高い親和性で特異的に結合し、受容体との相互作用およびその後の下流シグナル伝達を防ぎます。 Tralokinumab は、アトピー性皮膚炎 (AD) の研究に使用できます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1044515-88-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD)[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *